SIGN UP or LOGIN
YOUR CART
SUPPORT

Important Notice: Due to the Passover holiday our shipping department in Israel will be closed April 15-23.
Thank you for your patience and understanding.

  • US Name:

    Relafen

  • Israeli Names:

    Nabuco, Reliflex

  • Active Ingredients:

    Nabumetone

  • Brand Manufacturer:

    GSK

  • Manufacturer Location:

    Israel

  • Click here to view Product Insert

Relafen

Nabumetone is a non-steroidal anti-inflammatory drug (NSAID). NSAIDs are used to relieve pain and inflammation.

Brand Reliflex500mg20 Tablets 9311 GSK 483
-
+
$25.30
spinner
Generic Nabuco 500mg20 Tablets22546 UniPharm 482
-
+
$11.00
spinner

Nabumetone works by blocking the action of a substance in the body called cyclo-oxygenase (COX). Cyclo-oxygenase is involved in the production of various chemicals in the body, some of which are known as prostaglandins. Prostaglandins are produced by the body in response to injury and certain diseases and conditions, and cause pain, swelling and inflammation. Nabumetone blocks the production of these prostaglandins and is therefore effective at reducing inflammation and pain.

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Typically Under 7 days

Is Herbal Medication Better For You?

Many people immediately assume that natural alternatives to conventional medicine are always safe and effective and give little thought to potential side effects or interactions with other medications. The increase in popularity of herbal medicine

Read More »
couple woman with cancer
Cancer

Cancer and Israel’s Cutting Edge Tech

By Linda Dinovitz   “Cancer is a huge, global public-health problem. Without warning, it strikes people of all socio-economic strata, all ages, and all races… Though the rate of cancer deaths for Jews in Israel is among the lowest

Read More »
Covid vaccine

Worried About Local Vaccination Levels?

Look around you. Most TV commentators and other sources of information are looking at the “big picture” and so when they report on levels of immunization now achieving a “healthy” level of 50% of the

Read More »